Sustained dysfunction of myocardial contractility after short periods of coronary artery occlusion and reperfusion has been termed "stunned myocardium". Isoflurane may improve the recovery of regional myocardial contractility in stunned myocardium. The purpose of the present study was to determine if isoflurane prevents depletion of high energy phosphates after myocardial ischaemiareperfusion and if the reduction in cardiac work during isoflurane anaesthesia contributes to the preservation of high energy phosphate metabolism in an acute canine model. Mongrel dogs were allocated to one of three groups: controls, anaesthetized with urethane and chloralose; ISO group, isoflurane administered before ischaemia; and ISOc group, heart rate and mean arterial pressure controlled to approximately match baseline values. The left anterior descending (LAD) coronary artery was occluded for 15 min and then reperfused for 60 min during 1.5% end-tidal isoflurane anaesthesia. Full thickness samples of myocardium were obtained from the reperfused area (supplied by the LAD) and the non-ischaemic area (supplied by the left circumflex coronary artery). The concentrations of adenosine monophosphate (AMP), adenosine diphosphate (ADP), adenosine triphosphate (ATP), creatine phosphate (CP) and lactate in the endocardial portion of the myocardium were measured. Arterial pressure, aortic flow in the ascending aorta and rate-pressure product decreased significantly after isoflurane. Although the concentration of ATP of the reperfused area in the control group showed a significant reduction 60 min after reperfusion, the ISO and ISOc groups had significantly greater concentrations. Isoflurane anaesthesia maintained myocardial high energy phosphate metabolism in reperfused myocardium. We conclude that the reduction in cardiac work played only a minor role in the ATP-sparing effect of isoflurane. (Br.
Brief episodes of ischaemia that do not produce myocardial necrosis can result in reversible contractile dysfunction that persists long after relief of the ischaemia. This reversible post-ischaemic myocardial dysfunction is termed "stunned myocardium" [1, 2] .
Depletion of myocardial high energy phosphate concentrations has been postulated as one of the causes of this sustained myocardial dysfunction [3] [4] [5] [6] ; during ischaemia, adenosine triphosphate (ATP) is degraded to metabolites such as adenosine, hypoxanthine and inosine, which readily diffuse across cell membranes and are therefore washed out of the myocardium into the coronary sinus at the time of reperfusion [7] [8] [9] . The loss of these precursors from the reperfused myocardium limits the re-synthesis pathway and is believed to account, in part, for the prolonged ATP depletion observed after reperfusion.
Isoflurane has been used widely in patients with ischaemic heart disease. Recently, several reports have suggested that halogenated inhalation anaesthetics accelerate post-ischaemic recovery in stunned myocardium [10, 11] ; however, the mechanisms of these effects have not been well denned. Warltier and colleagues [10] reported that pre-ischaemic inhalation of isoflurane and halothane facilitated recovery of regional myocardial contractility of stunned myocardium in chronically instrumented dogs. In contrast, Belo and Mazer [12] reported that both anaesthetics depressed regional myocardial contractility when they were inhaled after ischaemiareperfusion in an open-chest canine model.
Recently, we reported that isoflurane improved regional myocardial contractility and preserved high energy phosphate concentrations in stunned myocardium in acutely instrumented dogs [13] . However, the reduction in cardiac work induced by isoflurane may have played an important role in myocardial protection in our previous study because the baseline haemodynamic state differed from that in the control group. Comparisons were performed between different anaesthetic regimens in our previous study. To exclude the influences of these factors, the present study was conducted using an identical anaesthetic technique for the baseline, and an additional isoflurane group where haemodynamic state was matched to the control group. The purpose of the present study was to determine if isoflurane prevents depletion of high energy phosphates after myocardial ischaemia-reperfusion and if the reduction in cardiac work during isoflurane anaesthesia contributes to the preservation of high energy phosphate metabolism in an acute canine model.
Materials and methods
This study was approved by our Institutional Committee on Animal Research. Mongrel dogs of both sexes, weighing between 10 and 15 kg, were anaesthetized with sodium thiamylal 25 mg kg" 1 i.v. After tracheal intubation, the lungs were ventilated mechanically with room air to maintain normocapnia. Anaesthesia was maintained with a combination of morphine 1.5 mg kg" 1 i.v. and a mixture of a-chloralose 45 mg ml" 1 and urethane 450 mg ml" 1 (lml kg" 1 i.v. initially and 0.3 ml kg" 1 h" 1 by infusion). Arterial blood pH and blood-gas tensions were maintained with physiological limits by adjusting ventilatory frequency and tidal volume or by i.v. infusion of 8.4% sodium bicarbonate when necessary. Body temperature was maintained at 37 °C with a heating pad. A 14-gauge catheter was inserted into the aorta via the left carotid artery and connected to a transducer for continuous monitoring of arterial pressure and blood sampling. A left thoracotomy was performed at the fifth intercostal space. The lung was retracted carefully and the heart suspended in a pericardial cradle. A precalibrated electromagnetic flow probe (Nihon Kohden, Japan) was placed around the ascending aorta to measure aortic flow Va. A 0.5-m segment of the left anterior descending (LAD) coronary artery was dissected free from the surrounding tissue distal to the first diagonal branch. The ECG was monitored using limb lead II and an epicardial lead to detect ischaemia.
After surgery was completed, the animal was allowed to stabilize for at least 30 min. Dogs were allocated to one of three groups. The control group received a continuous infusion of a combination of achloralose and urethane. The ISO group was given 1 MAC isoflurane (1.5% end-tidal concentration) before ischaemia. The ISOc group was given the same dose of isoflurane as the ISO group, but, atrial pacing was used in combination with constriction of the descending aorta to maintain heart rate and mean arterial pressure at the same values as those observed in each individual before isoflurane. End-tidal concentrations of isoflurane were measured with a calibrated Datex anaesthetic agent monitor.
Baseline values of heart rate (HR), systolic, diastolic and mean arterial pressure (SAP, DAP and MAP, respectively) and Va were recorded on an eight-channel pen recorder (Polygraph, Nihon Kohden, Japan). Rate-pressure product (RPP) was calculated as an index of cardiac work. Thereafter, the LAD was occluded for 15 min and reperfused for 60 min. Neither intraventricular catheterization nor implantation of ultrasonic crystals was performed nor were any antifibrillatory agents given during the experiment. Haemodynamic measurements were performed at baseline, after isoflurane, 5, 10 and 15 min after LAD occlusion, and 5, 10, 15, 30 and 60 min after reperfusion.
Full thickness samples of myocardium were removed rapidly with scissors from the centre of the LAD area (the myocardium supplied by the LAD coronary artery), and the left circumflex (LCx) area (the myocardium supplied by the LCx coronary artery). Samples were obtained either before ischaemia or 60 min after reperfusion in each group. The ischaemic area was confirmed by colour changes (cyanosis to hyperaemia) of the myocardial surface. The samples were immediately pressed and frozen in clamps chilled in liquid nitrogen, so that the endocardial portion of the myocardium could be taken separately for analysis.
The endocardial samples were pulverized in a mortar with a pestle precooled with liquid nitrogen and then extracted with perchloric acid. The concentrations of adenosine monophosphate (AMP), adenosine diphosphate (ADP), ATP, creatine phosphate and lactate in neutralized perchloric acid extracts were measured by standard enzymatic techniques [14] .
STATISTICAL ANALYSIS
All values are expressed as mean (SEM) . Haemodynamic differences between groups and within each group were compared by two-way ANOVA with repeated measures, and Fisher's least significant difference. Metabolic data were compared by one-way ANOVA and Fisher's least significant difference. Where appropriate, the chi-square test was performed. P < 0.05 was considered statistically significant.
Results
We studied 57 dogs. Three of 13 dogs in the control group and six of 16 dogs in the ISOc group died of ventricular fibrillation during occlusion or reperfusion. None of the dogs in the ISO group suffered life-threatening arrhythmia (P < 0.05 compared with controls). Six dogs in each group were killed just before LAD occlusion for measurement of myocardial metabolites. Haemodynamic and metabolic data were obtained from 10 dogs in the control, ISO and ISOc groups.
Haemodynamic data are summarized in table 1. There were no significant differences among the three groups in baseline values. After inhalation of 1 MAC of isoflurane, significant decreases in SAP, DAP, MAP, Va and RPP were observed in the ISO group. LAD occlusion and reperfusion did not cause significant changes in HR, SAP, DAP, MAP and RPP in the control group. Va decreased slightly after LAD occlusion in the control group.
Myocardial metabolic data just before LAD occlusion and 60 min after reperfusion are summarized in table 2. Before LAD occlusion, there were no significant differences between the groups in high energy phosphates, creatine phosphate or lactate. There were also no significant differences between LAD and LCx areas before ischaemia. Sixty minutes after reperfusion, high energy phosphates and lactate were maintained at almost preocclusion concentrations in the LCx area (without ischaemic episode) in all groups. In contrast, the Table 1 Mean (SEM) haemodynamic variables in the control, ISO and ISOc groups. HR = heart rate; SAP = systolic, DAP = diastolic and MAP = mean arterial pressures; Ka = aortic flow; RPP = rate-pressure product. Baseline = Before isoflurane anaesthesia; pre OCC = before LAD occlusion, n = 10 in each group. Significant differences (P < 0.05) compared with: * baseline values; + corresponding time value in the control and ISOc groups; * corresponding time value in the control group (8) 130 (5) 149 (8) 148 (7) 145 (7) 110 (8) 109 (7) 112 (8) 126 (7) 126 (5) 128 (5) 1.6(0.1) 1.6(0.1) 1.6(0.1) RPP (100 mm Hg min" (8) 123 (6) 130 (5) 149 (8) 103 ( 137 (7) 122 (6) 135 (6) 145 (7) 92 (5)*+ 135 (4) 110 (7) 61 (3)*+ 110 (4) 127 (7) 72 ( 137 (7) 125 (6) 135 (6) 145 (8) 90 (4)*+ 135 (4) 111 (8) 59 (3)*+ 111 (4) 127 (8) 72 ( 137 (9) 126 (6) 135 (6) 143 (7) 90 ( 135 (9) 122 (6) 132 (8) 143 (7) 92 (4) 132 (8) 123 (6) 131 (8) 143 (8) 94 (4) 129 (8) 123 (6) 130 (8) 142 (8) 93 (4) 124 (12) 123 (5) 128 (7) 144 (8) 95 (4)*+ 138 (5) 111 (8) 64 ( Table 2 Effects of isoflurane on myocardial metabolism of reperfused myocardium. ATP = Adenosine triphosphate; ADP = Adenosine diphosphate; AMP = adenosine monophosphate; CP = creatine phosphate. LAD = Myocardium supplied by the LAD (ischaemic and reperfused area); LCx = myocardium supplied by LCx (non-ischaemic area LAD area 60 min after LAD reperfusion showed significantly lesser concentrations of ATP than before occlusion in all groups. The ISO and ISOc groups showed significantly greater concentrations of myocardial ATP in the LAD areas than the controls 60 min after reperfusion ( fig. 1 ). Although the reperfused area showed a lesser concentration of endocardial ATP than the non-ischaemic area after reperfusion in the ISO group, it still had the greatest ATP concentration of all of the groups. Myocardial ADP concentration in the reperfused area decreased significantly in the control and ISO groups after ischaemia and reperfusion. AMP concentration in the reperfused area increased in the control and ISO groups after reperfusion; however, AMP concentrations in the ISO and ISOc groups remained less than those in the controls at the same time. Although the concentration of creatine phosphate in the reperfused area showed no significant change in the control group, it increased significantly ("overshoot") in the ISO and ISOc groups after reperfusion. Lactate concentrations in the reperfused area increased significantly in the control and ISO groups after reperfusion.
Discussion
There is good evidence [3] [4] [5] [6] , confirmed by the present study, that there is prolonged depletion of high-energy phosphates in reperfused myocardium after a brief period (15 min) of coronary artery occlusion and reperfusion. This finding is important as myocardial ATP content plays an important role in maintaining normal mechanical performance [15] and cell viability [16] . During ischaemia, ATP is degraded to metabolites such as adenosine, hypoxanthine and inosine. Because these catabolites are membrane permeable [7] [8] [9] , they are lost from the myocardial cell during reperfusion. Restoration of ATP thus requires de novo synthesis of purines, a relatively slow process [9] compared with rephosphorylation of ATP catabolites by oxidative phosphorylation and the so-called "salvage pathways" [17] . ATP concentration in the reperfused area was approximately 23 % less than that of the non-ischaemic area in the control group in our present study. On the other hand, there have been some reports [18] [19] [20] that depletion of ATP per se does not contribute to the delayed recovery of myocardial contractility in stunned myocardium; thus, the mechanisms of myocardial stunning are still open to debate. Intracellular calcium excess [21] [22] [23] , oxygenderived free radical production [24, 25] , disruption of myofibrillar energy use [26] , damage to the calcium transport system of the sarcoplasmic reticulum [27] , neutrophil accumulation [28] , enhanced energy expenditure by intracellular calcium transport [29] , unchanged oxygen consumption in reperfused myocardium [30] and ATP-dependent potassium channels [31] have all been suggested.
We have not confirmed that 15 min of ischaemia did not cause infarction in our model, or that reversible contractile dysfunction occurred in the ischaemic-reperfused region. Although this is a limitation of the present study, it is widely known that canine myocardium in situ does not show infarction until after 20 min of ischaemia [32] . Earlier studies [33, 34] used 15 min of ischaemia to stun the myocardium, and one demonstrated that there was no infarction in the stunned region [33] . Moreover, we used dogs which are well known to have a wide variability in collateral blood flow. Although isoflurane may contribute to the cardioprotective effect by improving collateral blood flow, we could not confirm this in our study.
There is some controversy on the effects of isoflurane on the ischaemic heart. Isoflurane has been found to reduce the extent of myocardial necrosis by 35 % compared with controls, 6 h after LAD occlusion in thiamylal anaesthetized openchest dogs [35] . In contrast, isoflurane impaired regional myocardial contractility in open-chest dogs with critical coronary artery stenoses [36] . Pask, England and Prys-Roberts [37] reported that isoflurane inhibited the activity of myonbrillar ATPase in isolated bovine ventricular muscle. This effect may help to maintain ATP concentrations, as it implies inhibition of ATP consumption during ischaemia and reperfusion. The present study was designed to study the cardioprotective effect of isoflurane in stunned myocardium by measuring high energy phosphates, creatine phosphate and lactate concentrations by full thickness biopsy of the myocardium. We showed that ATP was preserved in the ISO group but not in the control group.
The mechanism by which isoflurane preserves ATP content in stunned myocardium is not known but it seems likely that it involves ATP synthesis, utilization, or both. Kashimoto [38] reported that isoflurane maintained ATP concentration at 89 % of that in non-ischaemic heart 12 min after 8 min of global ischaemia in an isolated rat heart-lung preparation, which is in accord with our findings. Although ATP utilization might be increased by forcing the haemodynamic measures to match baseline values during the ischaemic and reperfusion periods, there was no significant difference in ATP content in the reperfused area between the ISO and ISOc groups. This is clear evidence that the reduction in cardiac work does not play an important role in the ATP-sparing effects of isoflurane in stunned myocardium.
It is impossible to tell if these effects occur during ischaemia or reperfusion from this study alone. A recent study by Warltier and colleagues [10] did shed some light, however. They reported that 2% isoflurane facilitated the recovery of regional myocardial contractility of stunned myocardium in chronically instrumented dogs. They administered isoflurane continuously from 2 h before ischaemia to 5 h after reperfusion. They also observed an improvement in myocardial contractility in the group which was emerging from anaesthesia at die time of reperfusion, while the administration of isoflurane in stunned myocardium after reperfusion caused a reduction in myocardial contractility in a dosedependent manner [12] . Thus we speculate that the myocardial protective effects of isoflurane in stunned myocardium may occur during ischaemia but not during reperfusion.
Other mechanisms for the cardioprotective effects of isoflurane may exist, as the ISOc group showed significantly greater concentrations of ATP and creatine phosphate than the control group in the present study. It has been reported that overshoot of creatine phosphate concentrations is never observed in severely damaged myocardium [39] . Therefore, we suggest that isoflurane has a cardioprotective effect which does not depend on a reduction in cardiac work in stunned myocardium. The loss of control of intracellular calcium homeostasis with calcium overload plays an important role in reperfusion injury and arrhythmia [40] . Recently, it has been reported that isoflurane reduces calcium influx through calcium channels [41] and calcium release from the sarcoplasmic reticulum [42] of cardiac cells. These effects may contribute to the protection of stunned myocardium; reduced intracellular calcium concentrations may preserve myocardial ATP as excess calcium transport consumes ATP.
In conclusion, after a brief period (15 min) of myocardial ischaemia followed by 60 min of reperfusion, isoflurane resulted in greater myocardial ATP concentrations than the control groups even when the cardiac work was restored to near baseline values. The reduction in cardiac work plays only a minor role in the ATP-sparing effect of isoflurane.
